These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR. Whitby PW, Carter KB, Burns JL, Royall JA, LiPuma JJ, Stull TL. J Clin Microbiol; 2000 Dec; 38(12):4305-9. PubMed ID: 11101555 [Abstract] [Full Text] [Related]
23. Predictors of mortality in adults with cystic fibrosis. Courtney JM, Bradley J, Mccaughan J, O'Connor TM, Shortt C, Bredin CP, Bradbury I, Elborn JS. Pediatr Pulmonol; 2007 Jun; 42(6):525-32. PubMed ID: 17469153 [Abstract] [Full Text] [Related]
24. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center. Campana S, Taccetti G, Ravenni N, Masi I, Audino S, Sisi B, Repetto T, Döring G, de Martino M. J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902 [Abstract] [Full Text] [Related]
25. Development of a novel PCR assay for the identification of the black yeast, Exophiala (Wangiella) dermatitidis from adult patients with cystic fibrosis (CF). Nagano Y, Elborn JS, Millar BC, Goldsmith CE, Rendall J, Moore JE. J Cyst Fibros; 2008 Nov; 7(6):576-80. PubMed ID: 18571996 [Abstract] [Full Text] [Related]
26. Identification of lysine positive non-fermenting gram negative bacilli (Stenotrophomonas maltophilia and Burkholderia cepacia complex). Gautam V, Ray P, Vandamme P, Chatterjee SS, Das A, Sharma K, Rana S, Garg RK, Madhup SK, Mahajan M, Sharma M. Indian J Med Microbiol; 2009 Nov; 27(2):128-33. PubMed ID: 19384035 [Abstract] [Full Text] [Related]
27. Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis. Wellinghausen N, Köthe J, Wirths B, Sigge A, Poppert S. J Clin Microbiol; 2005 Aug; 43(8):4070-5. PubMed ID: 16081953 [Abstract] [Full Text] [Related]
28. Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes. Anuj SN, Whiley DM, Kidd TJ, Bell SC, Wainwright CE, Nissen MD, Sloots TP. Diagn Microbiol Infect Dis; 2009 Feb; 63(2):127-31. PubMed ID: 19026507 [Abstract] [Full Text] [Related]
29. Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia. Tomlin KL, Coll OP, Ceri H. Can J Microbiol; 2001 Oct; 47(10):949-54. PubMed ID: 11718549 [Abstract] [Full Text] [Related]
31. A rapid culture independent methodology to quantitatively detect and identify common human bacterial pathogens associated with contaminated high purity water. Minogue E, Tuite NL, Smith CJ, Reddington K, Barry T. BMC Biotechnol; 2015 Feb 18; 15(1):6. PubMed ID: 25888294 [Abstract] [Full Text] [Related]
32. Microbiology of airway disease in a cohort of patients with cystic fibrosis. Lambiase A, Raia V, Del Pezzo M, Sepe A, Carnovale V, Rossano F. BMC Infect Dis; 2006 Jan 11; 6():4. PubMed ID: 16405721 [Abstract] [Full Text] [Related]
33. [Microbiological diagnostics in the patients with cystic fibrosis]. Augustynowicz-Kopeć E. Pneumonol Alergol Pol; 2014 Jan 11; 82(4):327-9. PubMed ID: 24964234 [No Abstract] [Full Text] [Related]
34. [Molecular epidemiology of Stenotrophomonas maltophilia strains isolated from paediatric patients]. Köseoğlu O, Sener B, Gür D. Mikrobiyol Bul; 2004 Jan 11; 38(1-2):9-19. PubMed ID: 15293897 [Abstract] [Full Text] [Related]
35. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. Hogardt M, Schmoldt S, Götzfried M, Adler K, Heesemann J. J Antimicrob Chemother; 2004 Dec 11; 54(6):1057-61. PubMed ID: 15509615 [Abstract] [Full Text] [Related]
36. Use of selective medium for Burkholderia cepacia isolation in respiratory samples from cystic fibrosis patients. da Silva Filho LV, Velloso Lde F, Bento CN, Gytin E, Tateno AF, Levi JE, Rodrigues JC, Ramos SR. Rev Inst Med Trop Sao Paulo; 2002 Dec 11; 44(4):203-8. PubMed ID: 12219111 [Abstract] [Full Text] [Related]
37. A novel strategy for the isolation and identification of environmental Burkholderia cepacia complex bacteria. Vanlaere E, Coenye T, Samyn E, Van den Plas C, Govan J, De Baets F, De Boeck K, Knoop C, Vandamme P. FEMS Microbiol Lett; 2005 Aug 15; 249(2):303-7. PubMed ID: 16000240 [Abstract] [Full Text] [Related]
38. Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex. Herasimenka Y, Cescutti P, Impallomeni G, Campana S, Taccetti G, Ravenni N, Zanetti F, Rizzo R. J Cyst Fibros; 2007 Apr 15; 6(2):145-52. PubMed ID: 16860003 [Abstract] [Full Text] [Related]
39. Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis. Anderson SW, Stapp JR, Burns JL, Qin X. J Clin Microbiol; 2007 Feb 15; 45(2):529-35. PubMed ID: 17135443 [Abstract] [Full Text] [Related]
40. A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients. Laine L, Perry JD, Lee J, Oliver M, James AL, De La Foata C, Halimi D, Orenga S, Galloway A, Gould FK. J Cyst Fibros; 2009 Mar 15; 8(2):143-9. PubMed ID: 19097827 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]